Application 012911

Type
NDA
Sponsor
HRA PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001METOPIRONEMETYRAPONETABLET;ORAL250MGNoNo
002METOPIRONEMETYRAPONECAPSULE;ORAL250MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N012911-001METOPIRONEMETYRAPONE250MGTABLET / ORALApproved before 1982
N012911-002METOPIRONEMETYRAPONE250MGCAPSULE / ORALRLD, RS1996-08-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N012911-001METOPIRONE250MGTABLET / ORALApproved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-09011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N012911-001METOPIRONE250MGTABLET / ORALApproved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-0931067a03dcf5…
2025-08-23 18:47 UTC2025-08N012911-001METOPIRONE250MGTABLET / ORALApproved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-096a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N012911-001METOPIRONE250MGTABLET / ORALApproved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-09fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N012911-001METOPIRONE250MGTABLET / ORALApproved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-09b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N012911-001METOPIRONE250MGTABLET / ORALApproved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-0903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N012911-001METOPIRONE250MGTABLET / ORALApproved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-092680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N012911-001METOPIRONE250MGTABLET / ORALApproved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-095bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N012911-001METOPIRONE250MGTABLET / ORALApproved before 1982d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-09d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N012911-001METOPIRONE250MGTABLET / ORALApproved before 1982d06236e962d9…
2024-10-29 15:01 UTC2024-10N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-09d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N012911-001METOPIRONE250MGTABLET / ORALApproved before 198279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-0979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N012911-001METOPIRONE250MGTABLET / ORALApproved before 1982301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-09301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N012911-001METOPIRONE250MGTABLET / ORALApproved before 19821e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-091e350fbaab3a…
2024-05-31 18:47 UTC2024-05N012911-001METOPIRONE250MGTABLET / ORALApproved before 19828072bd15b7f6…
2024-05-31 18:47 UTC2024-05N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-098072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N012911-001METOPIRONE250MGTABLET / ORALApproved before 19825c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-095c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N012911-001METOPIRONE250MGTABLET / ORALApproved before 19825d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-095d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N012911-001METOPIRONE250MGTABLET / ORALApproved before 19824b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-094b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N012911-001METOPIRONE250MGTABLET / ORALApproved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-0974a2ff9319b5…
2022-03-09 01:35 UTC2022-03N012911-001METOPIRONE250MGTABLET / ORALApproved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-09bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N012911-001METOPIRONE250MGTABLET / ORALApproved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12N012911-002METOPIRONE250MGCAPSULE / ORALRLD, RS1996-08-09782e0a99824c…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MetopironeMETYRAPONEESTEVE PHARMACEUTICALS, S.A.4046b167-7a46-8f4a-e063-6394a90a147f2026-05-19Warnings, Adverse reactionsExact identifier
application applno (NDA): 012911
application number: NDA012911
MetopironeMETYRAPONEHRA Pharma Rare Diseases3a27d0ef-83a7-4e1c-9430-46a3326ee8d82026-01-07Warnings, Adverse reactionsExact identifier
application applno (NDA): 012911
application number: NDA012911
ndc (product): 76336-455

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
76336-455MetopironeMetyraponeHRA Pharma Rare DiseasesNDACurrent
76336-455MetopironeMetyraponeLaboratoire HRA PharmaNDACurrent
76336-455MetopironeMetyraponeHRA Pharma Rare DiseasesNDACurrent
76336-455MetopironeMetyraponeHRA Pharma Rare DiseasesNDACurrent
76336-455MetopironeMetyraponeHRA Pharma Rare DiseasesNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
74900SUPPL 2023-07-27
74898SUPPL 2023-07-26
72059SUPPL2022-09-10
72055SUPPL2022-09-09
61987SUPPL2020-02-27
61928SUPPL2020-02-21
56092SUPPL2018-10-24
56084SUPPL2018-10-23
10827SUPPL2014-03-04
348SUPPL2014-03-04
12041SUPPL2010-11-08
10826SUPPL2010-11-04
347SUPPL2004-05-07